Columbia‘s Lab-to-Market Life Science Accelerators are designed to support the advancement of groundbreaking therapeutic and medical device research through training, project funding, mentorship, and expert guidance. Each program provides critical support to Columbia faculty-led projects, propelling their innovations from the lab to real-world applications. Teams whose pre-proposals are selected will be invited to participate in a 9-week Life Science Boot Camp.
Â
The 2024 - 2025 cycle focuses on:
Â
Therapeutics/Drug Development
Accelerating Cancer Therapeutics | ACT
Translational Therapeutics Accelerator | TRx
Â
Medical Technologies/Devices/Diagnostics/Software/Platform Technologies
Biomedical Engineering Technology Accelerator (formerly Columbia-Coulter program) | BiomedX
To learn more, please register for one of the following informational sessions by clicking the RSVP button below!Â
Accelerating Cancer Therapeutics (ACT) is a therapeutic development accelerator program focused on providing funding, education, partnership, and mentorship to Columbia Investigators, with a goal of advancing novel cancer therapies from the lab towards the clinic. Advice and project guidance will be provided by a steering committee of academic and industry experts in the field of drug development.
The Irving Institute Accelerate Program is a therapeutic development accelerator platform that plays a central role in translating the outstanding basic science discoveries at Columbia University into commercial therapeutics. Through our Translational Therapeutics (TRx) accelerator award, we focus on providing funding, education, partnership and mentorship to Columbia Investigators, with a goal of advancing novel therapies from the lab towards the clinic. Advice and project guidance will be provided by a steering committee of academic and industry experts in the field of drug development.
The Columbia BioMedX program (formerly the Columbia-Coulter Translational Research Partnership) is a biomedical engineering technology accelerator that aims to catalyze the advancement of Columbia University technologies from the lab to the market. The program provides funding, education, resources, and mentorship to teams of clinicians, engineers, and scientists to develop solutions to unmet clinical needs, with the ultimate goal of bringing innovative research out of the lab to benefit society. Project support serves as a bridge to commercial investment, with awards granted to perform specific tasks needed to validate a commercial hypothesis (vs. a scientific hypothesis).
